Literature DB >> 83234

Recognition of idiotypes in lymphocyte interactions. I. Idiotypic selectivity in the cooperation between T and B lymphocytes.

D Hetzelberger, K Eichmann.   

Abstract

Idiotypic restrictions are demonstrated in vitro for the cooperation between T and B lymphocytes with specificity for Group A streptococcal carbohydrate. T helper cells which have been primed in vivo with anti-idiotypic antibodies to the A5A idiotype and which are therefore essentially A5A idiotype-positive, cooperate only with A5A idiotype-positive B cells, even when mixtures of A5A idiotype-positive and A5A idiotype-negative B cells are present. Essentially A5A idiotype-negative T helper cells that have been primed in vivo with Group A streptococcal vaccine after in vivo suppression with anti-A5A idiotypic antibody are unable to cooperate with B cells which have been primed with anti-A5A idiotype antibody and which are therefore essentially A5A idiotype-positive. Mixtures of A5A idiotype-negative and A5A idiotype-positive T cells cooperate with both A5A idiotype-negative and A5A idiotype-positive B cells. Idiotypic restrictions could not be demonstrated for T and B cells recognizing carrier and hapten determinants, respectively, in experiments in which the cooperation of genetically VH-identical T and B cells was compared to the cooperation of genetically VH-different T and B cells. The data are discussed with respect to various models for the communication between T and B cells. It is proposed that for successful T-B cooperation, ordinarily two types of T helper cells are required, one recognizing the antigen and the other recognizing the idiotype of the B cell.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 83234     DOI: 10.1002/eji.1830081205

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  38 in total

1.  Correlation of the Km(1) immunoglobulin allotype with anti-polysaccharide antibodies in Caucasian adults.

Authors:  D M Ambrosino; V A Barrus; G G DeLange; G R Siber
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

2.  Isoelectric focusing spectra of anti-bacterial alpha-amylase antibody unique for antigen-induced suppression.

Authors:  S Nakashima
Journal:  Immunology       Date:  1986-02       Impact factor: 7.397

Review 3.  Autoregulation of immune responses via idiotype network interactions.

Authors:  L S Rodkey
Journal:  Microbiol Rev       Date:  1980-12

Review 4.  Network regulation among T cells; conclusions from limiting dilution experiments.

Authors:  K Eichmann; K Fey; R Kuppers; I Melchers; M M Simon; H U Weltzien
Journal:  Springer Semin Immunopathol       Date:  1983

Review 5.  How many T cells help one B cell?

Authors:  H Waldmann; J Phillips
Journal:  Springer Semin Immunopathol       Date:  1980-05

6.  Hapten-specific T-cell responses to 4-hydroxy-3-nitrophenyl acetyl. II. Demonstration of idiotypic determinants on suppressor T cells.

Authors:  J Z Weinberger; R N Germain; S T Ju; M I Greene; B Benacerraf; M E Dorf
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

7.  The IgG2a antibody response to thyroglobulin is linked to the Igh locus in mouse.

Authors:  R C Kuppers; L D Epstein; I M Outschoorn; N R Rose
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

8.  Individual clones of carrier-specific T cells help idiotypically and isotypically heterogeneous anti-hapten B-cell responses.

Authors:  S Cammisuli; M H Schreier
Journal:  Immunology       Date:  1981-07       Impact factor: 7.397

9.  T-cell-dependent oscillations of IgM antibody affinity during the immune response to DNP-Dextran to low or high epitope density.

Authors:  L Nencioni; C Mancini; C Pini; G Doria
Journal:  Immunology       Date:  1982-09       Impact factor: 7.397

10.  Epitope-specific regulation. II. A bistable, Igh-restricted regulatory mechanism central to immunologic memory.

Authors:  L A Herzenberg; T Tokuhisa; D R Parks; L A Herzenberg
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.